-
1
-
-
77955224519
-
Systemic inflammation and comorbidity in COPD: A result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence
-
N.J. Sinden, and R.A. Stockley Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence Thorax 65 2010 930 936
-
(2010)
Thorax
, vol.65
, pp. 930-936
-
-
Sinden, N.J.1
Stockley, R.A.2
-
2
-
-
42749089629
-
Atherosclerosis, COPD and chronic inflammation
-
M. Bäck Atherosclerosis, COPD and chronic inflammation Resp Med 2008 60 65
-
(2008)
Resp Med
, pp. 60-65
-
-
Bäck, M.1
-
3
-
-
34548277025
-
From COPD to chronic systemic inflammatory syndrome?
-
L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799
-
(2007)
Lancet
, vol.370
, pp. 797-799
-
-
Fabbri, L.M.1
Rabe, K.F.2
-
5
-
-
84884305030
-
Cardiovascular safety in patients receiving roflumilast for the treatment of COPD
-
W.B. White, G.E. Cooke, and P.R. Kowey et al. Cardiovascular safety in patients receiving roflumilast for the treatment of COPD Chest 144 2013 758 765
-
(2013)
Chest
, vol.144
, pp. 758-765
-
-
White, W.B.1
Cooke, G.E.2
Kowey, P.R.3
-
6
-
-
84857799573
-
Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
-
[e2]
-
E. Ingelsson, L. Yin, and M. Bäck Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease J Allergy Clin Immunol 129 2012 702 707 [e2]
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 702-707
-
-
Ingelsson, E.1
Yin, L.2
Bäck, M.3
-
7
-
-
84864624377
-
Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib
-
M. Bäck, L. Yin, and E. Ingelsson Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib Eur Heart J 33 2012 1928 1933
-
(2012)
Eur Heart J
, vol.33
, pp. 1928-1933
-
-
Bäck, M.1
Yin, L.2
Ingelsson, E.3
-
8
-
-
84871132035
-
The leukotriene receptor antagonist montelukast and aortic stenosis
-
M. Bäck, L. Yin, E. Nagy, and E. Ingelsson The leukotriene receptor antagonist montelukast and aortic stenosis Br J Clin Pharmacol 75 2013 280 281
-
(2013)
Br J Clin Pharmacol
, vol.75
, pp. 280-281
-
-
Bäck, M.1
Yin, L.2
Nagy, E.3
Ingelsson, E.4
-
9
-
-
80052663748
-
Increased adverse events after percutaneous coronary intervention in patients with COPD: Insights from the National Heart, Lung, and Blood Institute dynamic registry
-
J.R. Enriquez, S.V. Parikh, and F. Selzer et al. Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry Chest 140 2011 604 610
-
(2011)
Chest
, vol.140
, pp. 604-610
-
-
Enriquez, J.R.1
Parikh, S.V.2
Selzer, F.3
-
10
-
-
0023257720
-
Coronary risk factors and survival probability from coronary and other causes of death
-
G. Farchi, A. Menotti, and S. Conti Coronary risk factors and survival probability from coronary and other causes of death Am J Epidemiol 126 1987 400 408
-
(1987)
Am J Epidemiol
, vol.126
, pp. 400-408
-
-
Farchi, G.1
Menotti, A.2
Conti, S.3
-
11
-
-
0025976487
-
Ventilatory function as a predictor of fatal stroke
-
D.P. Strachan Ventilatory function as a predictor of fatal stroke BMJ 302 1991 84 87
-
(1991)
BMJ
, vol.302
, pp. 84-87
-
-
Strachan, D.P.1
-
12
-
-
33845915111
-
Lung function and ischemic stroke incidence: The Atherosclerosis Risk in Communities study
-
A. Hozawa, J.L. Billings, E. Shahar, T. Ohira, W.D. Rosamond, and A.R. Folsom Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study Chest 130 2006 1642 1649
-
(2006)
Chest
, vol.130
, pp. 1642-1649
-
-
Hozawa, A.1
Billings, J.L.2
Shahar, E.3
Ohira, T.4
Rosamond, W.D.5
Folsom, A.R.6
-
13
-
-
0028793895
-
Respiratory function and risk of stroke
-
S.G. Wannamethee, A.G. Shaper, and S. Ebrahim Respiratory function and risk of stroke Stroke 26 1995 2004 2010
-
(1995)
Stroke
, vol.26
, pp. 2004-2010
-
-
Wannamethee, S.G.1
Shaper, A.G.2
Ebrahim, S.3
-
14
-
-
0037637605
-
Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study
-
P. Buch, J. Friberg, H. Scharling, P. Lange, and E. Prescott Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study Eur Respir J 21 2003 1012 1016
-
(2003)
Eur Respir J
, vol.21
, pp. 1012-1016
-
-
Buch, P.1
Friberg, J.2
Scharling, H.3
Lange, P.4
Prescott, E.5
-
15
-
-
84873956600
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
-
J. Vestbo, S.S. Hurd, and A.G. Agusti et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 2013 347 365
-
(2013)
Am J Respir Crit Care Med
, vol.187
, pp. 347-365
-
-
Vestbo, J.1
Hurd, S.S.2
Agusti, A.G.3
-
16
-
-
84864868710
-
Stroke prevention: An update
-
M.G. Bousser Stroke prevention: an update Front Med 6 2012 22 34
-
(2012)
Front Med
, vol.6
, pp. 22-34
-
-
Bousser, M.G.1
-
17
-
-
80054061446
-
Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: A Danish nationwide study of 7.4 million individuals
-
B.F. Sode, M. Dahl, and B.G. Nordestgaard Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals Eur Heart J. 32 2011 2365 2375
-
(2011)
Eur Heart J.
, vol.32
, pp. 2365-2375
-
-
Sode, B.F.1
Dahl, M.2
Nordestgaard, B.G.3
|